You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Resectable

Showing 1 - 25 of 2,698
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Potentially Resectable Hepatocellular Carcinoma Trial (FOLFOX-HAIC+Lenvatinib+Envolizumab)

Not yet recruiting
  • Potentially Resectable Hepatocellular Carcinoma
  • (no location specified)
Nov 16, 2023

NSCLC Trial (Durvalumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Jun 22, 2023

Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Trial (Cadonilimab, AK117, Oxaliplatin)

Not yet recruiting
  • Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
Jul 17, 2023

Candidates for Neoadjuvant Treatment in Resectable Pancreatic

Completed
  • Pancreatic Cancer
  • Neoadjuvant
  • Neoadjuvant treatment
  • (no location specified)
Nov 9, 2023

Resectable Hepatocellular Carcinoma Trial (Tislelizumab, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • (no location specified)
Mar 29, 2023

Borderline Resectable Carcinoma, Biliary Tract Cancer Trial in Washington (Durvalumab, Tremelimumab, Gemcitabine)

Not yet recruiting
  • Borderline Resectable Carcinoma
  • Biliary Tract Cancer
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023

Colon Cancer Trial in Lexington (TVB-2640, Placebo)

Recruiting
  • Colon Cancer
  • Lexington, Kentucky
    University of Kentucky
Jan 18, 2023

Intrahepatic Cholangiocarcinoma Trial in Padova (Liver transplantation)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Liver transplantation
  • Padova, Italy
    Azienda Ospedale Università di Padova
Oct 25, 2023

Lung Cancer Trial (Sacituzumab Govitecan, Pembrolizumab)

Not yet recruiting
  • Lung Cancer
  • (no location specified)
Sep 20, 2023

Hepatocellular Carcinoma Trial in Guangzhou (SIRT)

Not yet recruiting
  • Hepatocellular Carcinoma
  • SIRT
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 9, 2023

Pancreatic Ductal Adenocarcinoma Trial in Toronto (Durvalumab, Oleclumab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 22, 2023

Biliary Tract Tumors Trial (Total Neoadjuvant Treatment)

Not yet recruiting
  • Biliary Tract Neoplasms
  • Total Neoadjuvant Treatment
  • (no location specified)
Sep 7, 2023

Perihilar Cholangiocarcinoma Trial in Padova (Liver transplantation)

Not yet recruiting
  • Perihilar Cholangiocarcinoma
  • Liver transplantation
  • Padova, Italy
    Azienda Ospedale Università di Padova
Nov 5, 2023

Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,

Not yet recruiting
  • Pancreatic Cancer, Stage IB
  • +3 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Jan 4, 2023

Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)

Recruiting
  • Gastric Cancer
  • sintilimab+metronomic PLOF
  • Shanghai, China
    Huashan Hospital, Fudan University
Sep 22, 2023

Hepatocellular Carcinoma Resectable Trial in Fuzhou (neoadjuvant therapy)

Not yet recruiting
  • Hepatocellular Carcinoma Resectable
  • neoadjuvant therapy
  • Fuzhou, Fujian, China
    The First Affiliated Hospital of Fujian Medical University
Aug 19, 2023

Resectable Hepatocellular Carcinoma Trial (Cadonilimab, TACE, Surgery)

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • (no location specified)
Dec 12, 2022

ctDNA in Resectable and Borderline Resectable Pancreatic Cancer

Recruiting
  • Pancreatic Cancer
  • SIGNATERA™ ctDNA testing
  • Fairfax, Virginia
    Inova Schar Cancer Institute
Oct 26, 2022

Stage III NSCLC Trial (Toripalimab, JS004, Pemetrexed)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • (no location specified)
Jun 3, 2023

Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Pancreas Adenocarcinoma
  • +2 more
  • Nab paclitaxel
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023

Colorectal Cancer, Resectable Colorectal Carcinoma Trial in Milan (Trastuzumab deruxtecan, Durvalumab, Panitumumab)

Active, not recruiting
  • Colorectal Cancer
  • Resectable Colorectal Carcinoma
  • Trastuzumab deruxtecan
  • +4 more
  • Milan, Lombardia/MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 26, 2023

Pancreatic Adenocarcinoma Trial in Dublin (Dose-Painted Intensity Modulated Radiotherapy)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Dose-Painted Intensity Modulated Radiotherapy
  • Dublin, Ireland
    St Luke's Radiation Oncology Network (SLRON)
Aug 29, 2023

Pancreatic Cancer Trial in Aurora (TTI-101)

Not yet recruiting
  • Pancreatic Cancer
  • Aurora, Colorado
    University of Colorado
Nov 30, 2023

NSCLC Trial in Beijing

Recruiting
  • NSCLC
    • Beijing, China
      Yuyan Wang
    Oct 10, 2023

    Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced

    Completed
    • Oral Cancer
    • PD-1 inhibitor+carboplatin+albumin-bound paclitaxel
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Memorial Hospital
    Nov 20, 2023